-+ 0.00%
-+ 0.00%
-+ 0.00%

REGENERON PHARMACEUTICALS, - TO ADVANCE UBAMATAMAB INTO CONFIRMATORY PHASE 3 TRIAL FOR LGSOC

路透·10/01/2026 15:35:00

请登录查看新闻详情